In one paragraphArticle in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
9 authors.
Brian D HardawayDivision of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.ORCID 0000-0003-0622-3494 Trevor P FidlerCardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0002-0758-9984 Mojdeh TavallaieDivision of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.ORCID 0000-0001-7166-2499 Kleopatra AvrampouDivision of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.ORCID 0009-0008-4422-5064 Cheng-Chieh HsuDivision of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.ORCID 0000-0002-3423-7159 Sandra SchiavoneDivision of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Tong XiaoDivision of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Nan WangDivision of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Alan R TallDivision of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.ORCID 0000-0002-7708-2417 Funding
Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3MMouse and Human Atherosclerotic TissueP01HL172741 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Hanrui Zhang · 2024 to 2026
$9.5MJAK2V617F, clonal hematopoiesis and atherosclerosisR01HL148071 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI NAN WANG · 2019 to 2026
$4.0MClonal hematopoiesis, inflammasomes and atherosclerosisR01HL155431 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ALAN richard TALL · 2021 to 2026
$3.7MNew therapeutic approaches in clonal hematopoiesis and atherosclerosisR01HL170157 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TALL, ALAN RICHARD · 2023 to 2023
$695kNCI NIH HHS P30 CA013696NHLBI NIH HHS P01 HL172741NHLBI NIH HHS R01 HL148071NHLBI NIH HHS R01 HL155431NHLBI NIH HHS R01 HL170157
6 · The paper itselfAbstract
Background –: The Methods and Results –: Chimeric Conclusions –: Aggressive LDL lowering reverses inflammasome activation and induces pro-resolving changes in macrophages in
Indexed as
absent in melanoma 2atherosclerotic plaque regressionbone marrowclonal hematopoiesisfoam cellsinflammasomeinflammationJak2V617F mutationLDLvascular biology
Identifiers
PMID40766664
PMCPMC12324260
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390